Peter Q. Harris

506 total citations
21 papers, 381 citations indexed

About

Peter Q. Harris is a scholar working on Psychiatry and Mental health, Pharmacology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Peter Q. Harris has authored 21 papers receiving a total of 381 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Psychiatry and Mental health, 4 papers in Pharmacology and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in Peter Q. Harris's work include Schizophrenia research and treatment (4 papers), Treatment of Major Depression (3 papers) and Hearing, Cochlea, Tinnitus, Genetics (2 papers). Peter Q. Harris is often cited by papers focused on Schizophrenia research and treatment (4 papers), Treatment of Major Depression (3 papers) and Hearing, Cochlea, Tinnitus, Genetics (2 papers). Peter Q. Harris collaborates with scholars based in United States, United Kingdom and Malaysia. Peter Q. Harris's co-authors include Joseph F. Lipinski, Matthew J. Friedman, Bruce M. Cohen, Susan J. Brown, Nicholas G. Bacopoulos, Julie Cole, B.M. Cohen, Harrison G. Pope, Nicholas J. Vardaxis and Barbara L. Jones and has published in prestigious journals such as American Journal of Psychiatry, Molecular Pharmacology and Life Sciences.

In The Last Decade

Peter Q. Harris

21 papers receiving 343 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Q. Harris United States 11 157 72 60 46 43 21 381
Hilde Lunde Norway 10 177 1.1× 36 0.5× 116 1.9× 58 1.3× 47 1.1× 16 486
Richard T Owen United Kingdom 12 103 0.7× 30 0.4× 92 1.5× 79 1.7× 69 1.6× 36 364
O Varoquaux France 12 71 0.5× 34 0.5× 103 1.7× 87 1.9× 83 1.9× 23 393
N. Bjørum Denmark 13 178 1.1× 83 1.2× 46 0.8× 72 1.6× 25 0.6× 21 446
Tom Ramsey United States 12 252 1.6× 54 0.8× 82 1.4× 77 1.7× 63 1.5× 14 395
I. Zieleniuk France 11 109 0.7× 15 0.2× 78 1.3× 67 1.5× 37 0.9× 14 365
Andrzej A. Zięba Poland 9 94 0.6× 96 1.3× 149 2.5× 77 1.7× 63 1.5× 39 554
Eric C. Dessain United States 7 293 1.9× 38 0.5× 59 1.0× 141 3.1× 26 0.6× 8 487
DavidM. Shaw United Kingdom 8 201 1.3× 91 1.3× 96 1.6× 146 3.2× 21 0.5× 9 364
Morselli Pl Italy 16 228 1.5× 20 0.3× 125 2.1× 75 1.6× 81 1.9× 45 682

Countries citing papers authored by Peter Q. Harris

Since Specialization
Citations

This map shows the geographic impact of Peter Q. Harris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Q. Harris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Q. Harris more than expected).

Fields of papers citing papers by Peter Q. Harris

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Q. Harris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Q. Harris. The network helps show where Peter Q. Harris may publish in the future.

Co-authorship network of co-authors of Peter Q. Harris

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Q. Harris. A scholar is included among the top collaborators of Peter Q. Harris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Q. Harris. Peter Q. Harris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cohen, Bruce M. & Peter Q. Harris. (2023). Currently available means to achieve personalized psychiatry. 39-40. 100105–100105. 1 indexed citations
2.
Cohen, Bruce M., Döst Öngür, Suzann M. Babb, & Peter Q. Harris. (2022). Diagnostic terms psychiatrists prefer to use for common psychotic and personality disorders. Journal of Psychiatric Research. 155. 226–231. 2 indexed citations
3.
Ravichandran, Caitlin, Suzann M. Babb, Döst Öngür, Peter Q. Harris, & Bruce M. Cohen. (2022). Survey of quality and clarity of methods and results reporting in 1 year of intervention studies published in high-impact medical and psychiatric journals. BMJ Open. 12(12). e061882–e061882. 1 indexed citations
4.
Vincenzi, Bruno, Ajay Duggal, Pamela Guglielmini, et al.. (2020). Neurokinin-1 antagonist orvepitant for EGFRI-induced pruritus in patients with cancer: a randomised, placebo-controlled phase II trial. BMJ Open. 10(2). e030114–e030114. 11 indexed citations
5.
6.
Carlyon, Robert P., John M. Deeks, Alexander J. Billig, et al.. (2018). Evaluation of Possible Effects of a Potassium Channel Modulator on Temporal Processing by Cochlear Implant Listeners. Journal of the Association for Research in Otolaryngology. 19(6). 669–680. 6 indexed citations
7.
Sanchez, Victoria A., et al.. (2018). Recruiting ENT and Audiology patients into pharmaceutical trials: evaluating the multi-centre experience in the UK and USA. International Journal of Audiology. 57(sup4). S96–S107. 10 indexed citations
8.
Murphy, Beth L., Andrew L. Stoll, Peter Q. Harris, et al.. (2012). Omega-3 Fatty Acid Treatment, With or Without Cytidine, Fails to Show Therapeutic Properties in Bipolar Disorder. Journal of Clinical Psychopharmacology. 32(5). 699–703. 36 indexed citations
9.
Harris, Peter Q., et al.. (2010). Mosby's dictionary of medicine, nursing and health professions. 26 indexed citations
10.
Oxenkrug, Gregory F. & Peter Q. Harris. (1988). Benzodiazepins attenuate clorgyline-induced stimulation of melatonin synthesis. Pharmacological Research Communications. 20. 143–144. 3 indexed citations
11.
Kellner, Charles H., et al.. (1985). Concurrent use of bromocriptine and fluphenazine.. PubMed. 46(10). 455–455. 1 indexed citations
12.
Lipinski, Joseph F., Frances R. Frankenburg, Mauricio Tohen, et al.. (1984). Open trial of S-adenosylmethionine for treatment of depression. American Journal of Psychiatry. 141(3). 448–450. 70 indexed citations
13.
Harris, Peter Q., Nicholas G. Bacopoulos, & Susan J. Brown. (1984). Measurement of homovanillic acid in human plasma by high-performance liquid chromatography with electrochemical detection. Journal of Chromatography B Biomedical Sciences and Applications. 309(2). 379–384. 12 indexed citations
14.
Stolk, Jon M., et al.. (1984). Serum dopamine-beta-hydroxylase activity in depression and anxiety.. PubMed. 19(4). 557–70. 5 indexed citations
15.
Harris, Peter Q., Susan J. Brown, Matthew J. Friedman, & Nicholas G. Bacopoulos. (1984). Plasma drug and homovanillic acid levels in psychotic patients receiving neuroleptics.. PubMed. 19(6). 849–60. 46 indexed citations
16.
Brown, Susan J. & Peter Q. Harris. (1984). Effects of hypophysectomy and immobilization stress on S-adenosylmethionne levels in rat adrenal glands. Life Sciences. 35(1). 97–104. 4 indexed citations
17.
Harris, Peter Q., Matthew J. Friedman, Bruce M. Cohen, & Thomas B. Cooper. (1983). Fluphenazine blood levels and clinical response. Journal of Clinical Psychopharmacology. 3(2). 113–113. 3 indexed citations
18.
Cohen, B.M., et al.. (1982). Amoxapine: neuroleptic as well as antidepressant?. American Journal of Psychiatry. 139(9). 1165–1167. 60 indexed citations
19.
Cohen, Bruce M., Joseph F. Lipinski, Peter Q. Harris, Harrison G. Pope, & Matthew J. Friedman. (1980). Clinical use of the radioreceptor assay for neuroleptics. Psychiatry Research. 2(2). 173–178. 37 indexed citations
20.
Stolk, Jon M., et al.. (1979). Genetic Analysis of Serum Dopamine-Beta-Hydroxylase Activity in Rats. Molecular Pharmacology. 16(3). 922–931. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hilde Lunde Breakdown of academic impact, for papers by Richard T Owen Breakdown of academic impact, for papers by O Varoquaux Breakdown of academic impact, for papers by N. Bjørum Breakdown of academic impact, for papers by Tom Ramsey Breakdown of academic impact, for papers by I. Zieleniuk Breakdown of academic impact, for papers by Andrzej A. Zięba Breakdown of academic impact, for papers by Eric C. Dessain Breakdown of academic impact, for papers by DavidM. Shaw Breakdown of academic impact, for papers by Morselli Pl
Rankless by CCL
2026